Doctor Paul Guedeney
Pitie Salpetriere APHP University Hospital, Paris (France)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure
Event: ESC Congress 2023
Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure
Session: Young Investigator Awards Session in Thrombosis
Outcomes following patent foramen ovale percutaneous closure according to the delay from last ischemic event
Event: ESC Congress 2022
Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure
Session: Patent foramen ovale closure and left atrial appendage closure
Supraventricular arrhythmia following patent foramen ovale percutaneous closure
Event: ESC Congress 2022
Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure
Session: Patent foramen ovale closure and left atrial appendage closure
Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation
Event: ESC Congress 2022
Topic: Aortic Valve Intervention
Session: Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis - report from an international registry
Event: ESC Congress 2022
Topic: Cardio-Oncology
Session: Cardio-oncology 1
First clinical experience with the wearable cardiac rhythm long-term monitoring cardioskin device
Event: ESC Congress 2020
Topic: Remote Patient Monitoring and Telehealth
Session: Wearables and the ECG: What Progress Are We Making?
Early aspirin discontinuation following acute coronary syndrome or percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Coronary Artery Disease (Chronic) ePosters
Incidence and delay of atrial tachycardia after patent foramen ovale closure
Event: ESC Congress 2020
Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure
Session: Interventional Cardiology ePosters
Indirect comparison of the safety and efficacy of alirocumab and evolocumab: from a comprehensive meta-analysis of 30 randomized controlled trials
Event: ESC Congress 2019
Topic: Lipid-Lowering Agents
Session: Lipid management and outcome
Incidence, risk factors and impact of readmission for heart failure after successful transcatheter aortic valve replacement
Event: ESC Congress 2019
Topic: Aortic Valve Intervention
Session: TAVR outcomes: the future is here
ESC 365 is supported by
